Gene Therapy Market By Application: Rare Diseases, Cancer Treatment, By End-Use: Research Institutions, Hospitals, By End-Use: Research Institutions, Hospitals, Segment Forecasts: 2024 - 2030
Gene Therapy Market Trends
The gene therapy market was valued at USD 10.4 billion in 2024 and is projected to grow at a CAGR of 28.1% from 2025 to 2030. Gene therapy is emerging as a revolutionary approach for treating rare diseases and cancer, providing new avenues for patient care.
Product Insights
The rare diseases application accounted for the largest share in 2024, capturing 58.6% of the market, as gene therapy addresses unmet medical needs in this segment. Cancer treatment applications are also expanding rapidly, supported by advancements in targeted therapies and personalized medicine.
End-Use Insights
Research institutions were the largest end-users in 2024, holding a 60.3% share of the market as they drive innovation and clinical trials in gene therapy. Hospitals are increasingly adopting these therapies, reflecting a shift towards more advanced treatment options for patients.
Regional Insights
North America led the gene therapy market with a 49.8% share in 2024, backed by strong regulatory support and significant investment in biotech innovations. The Europe region is anticipated to grow steadily, supported by favorable policies and increasing clinical trial activities.
GET A FREE SAMPLE
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.